Collagen Solutions PLC

Receive alerts
Market Cap:
£17.08 m
52 weeks high
52 weeks low

Viewing results 1-25 of 94


Collagen Solutions seeing “continued growth as expected”

“We are also progressing with infrastructure projects to increase our capacity for contract manufacturing while we also expand our tissue supply,” Jamal Rushdy said ahead of the company’s annual meeting later in Glasgow...

2 weeks, 5 days ago

Collagen Solutions financially well set for success

Last month it raised almost £6mln to propel it to the next level of commercial development. "We expect the fund raise should improve our chance of reaching profitability with no need for another," investors were told ...

on 9/7/19

Collagen Solutions receives Stateside boost

We take a closer look at Collagen Solutions, which received third-party validation of its business model in the form of outside investment from a blue-chip US agriculture company ...

on 20/5/19

Collagen Solutions jumps as it raises £6mln at a premium, including investment from US agriculture giant

Rosen’s Diversified, America’s fifth-largest beef processor, is investing £4.2mln into Collagen as part of its plans to get into the animal tissue-related biomedical products space...

on 20/5/19

Collagen Solutions expects full-year revenue to rise more than market forecasts

"We are pleased with our delivery of high double-digit growth within our core business representing a substantial turn-around of performance from our prior financial year,” chief executive Jamal Rushdy...

on 9/4/19

Collagen Solutions raises around £215,000 from sale of small stake in private marine biotechnology firm, Jellagen

Jamal Rushdy, Collagen Solutions’ CEO said "our decision to divest our shares does not preclude future potential opportunities to collaborate with Jellagen"...

on 20/2/19

Collagen Solutions waiting on CE Mark for ChondroMimetic knee cartilage scaffold

Results from an eight-year clinical extension study showed that ChondroMimetic was able to regenerate cartilage to a structural quality almost identical to native cartilage...

on 18/2/19

Collagen Solutions signs new ChondroMimetic licence and distribution deal in Indonesia

Rajawali Medika will work with Collagen to obtain regulatory approval and launch ChondroMimetic in Indonesia and possibly several other South East Asian countries...

on 31/1/19

Collagen Solutions rises as it signs manufacturing agreement for Excellagen wound-healing product

Collagen will manufacture Excellagen for New York-based Olaragen following a deal signed in 2018 between the latter and Gene Biotherapeutics, for whom Collagen originally made the product...

on 15/1/19

Collagen Solutions receives £1.54mln grant from Scottish government

The grant is part of the Scottish government’s plans to grow the life sciences sector in the sector from £5bn to £8bn by 2025...

on 7/1/19

Demand for Collagen Solutions’ products surges in first half

Even including the loss of a major customer in Korea, revenues jumped 13% in the first half to £2.10mln, driven by a rise in new and higher value contracts...

on 4/12/18

Collagen Solutions expects to report jump in first-half revenues

Revenues are expected to rise 13% to £2.10mln, driven by a rise in new and higher value customer deals...

on 23/10/18

Collagen Solutions adds COO and CBO to its board

COO Tom Hyland and CBO Lou Ruggiero will join the regenerative medicines group’s board with immediate effect...

on 3/9/18

Collagen Solutions on track to hit financial and operational targets this year

At today’s AGM, CEO Jamal Rushdy will tell investors that this business is making good progress in the lab and in the boardroom...

on 22/8/18

Collagen Solutions inks distribution deals with two new Chinese partners

The appointment of Dakewe Biotech and Shanghai Regenic Biomedical follows the restructuring of Collagen’s operations in China and the securing of export licences earlier this year...

on 21/8/18

Collagen Solutions looks to have put last year’s difficulties behind it with strong start to current year

Since reporting its full-year results on July 10, the AIM-listed shares have rallied over 38% in the past month to 3.65p currently, taking year-to-date gains to a third ...

on 17/8/18